| European Case Law Identifier: | ECLI:EP:BA:2001:T121297.20010514 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 May 2001 | ||||||||
| Case number: | T 1212/97 | ||||||||
| Application number: | 84302368.0 | ||||||||
| IPC class: | C12N 15/13 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Recombinant immunoglobulin preparations, methods for their preparation, DNA sequences, expression vectors and recombinant host cells therefor | ||||||||
| Applicant name: | Genentech, Inc., et al | ||||||||
| Opponent name: | Bristol-Myers Company Roche Diagnostics GmbH Protein Design Ortho Pharmaceutical Corp. Celltech Limited |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Oral presentation - state of the art (no) Main request - claim 1 - sufficiency of disclosure (no) Main request - claim 16 - novelty (no) First auxiliary request - claim 1- sufficiency of disclosure (no) Second auxiliary request - novelty (yes) Inventive step (yes) Adaptation of the description |
||||||||
| Catchwords: |
The information content made publicly available by a lecture cannot be put beyond reasonable doubt by any evidence of the lecturer alone, as the lecturer is in a quite different position to a member of the audience (see point 3 ff). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t971212eu1.html
Date retrieved: 17 May 2021